Available in 46 states not available in Arkansas, Indiana, Minnesota, or South Carolina
Pharmacologically, BPC-157 exhibits rapid absorption following administration, with studies in rats and dogs indicating a half-life of less than 30 minutes after intravenous or intramuscular delivery
Oral capsules or sublingual preparations deliver the peptide to the target tissue
Some insulin syringes come in 0.5 mL (50 unit) or 0.3 mL (30 unit) sizes
BPC-157 has emerged as one of the most promising peptides for ankle injury recovery, with research demonstrating accelerated healing of tendons, ligaments, and surrounding soft tissue structures
The activation of pro-migratory signals (FAKpaxillin) and pro-angiogenic factors (VEGF, EGR-1, nitric oxide) by BPC-157is a double-edged sword